Estonia Antihypertensive Medicine Sales is set to reach $2.05 Million by 2026 from $1.76 Million, will increase 17.1% per year. Italy, Spain and Australia respectively ranked numbers 2, 3 and 4 in this ranking.
How does Estonia perform in Antihypertensive?
Forecast: Renin-Angiotensin System Medicine Sales in Estonia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Estonia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Estonia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Estonia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Estonia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Estonia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Estonia
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Estonia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Use in Estonia
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Estonia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research